UBS Group’s Elanco Animal Health ELAN Stock Holding History

UBS Group’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-68,200	Closed	-$984K	–	9625
2024 Q2	$984K	Buy	+68,200	New	+$1.09M	﹤0.01%	4439
2023 Q2	–	Sell	-210,000	Closed	-$1.97M	–	9085
2023 Q1	$1.97M	Buy	210,000 +165,000	+367%	+$1.95M	﹤0.01%	3450
2022 Q4	$550K	Sell	45,000 -40,000	-47%	-$499K	﹤0.01%	4626
2022 Q3	$1.05M	Buy	+85,000	New	+$1.49M	﹤0.01%	3713
2022 Q2	–	Sell	-100,000	Closed	-$2.61M	–	10454
2022 Q1	$2.61M	Buy	100,000 +50,000	+100%	+$1.33M	﹤0.01%	3173
2021 Q4	$1.42M	Hold	50,000	–	–	﹤0.01%	4068
2021 Q3	$1.59M	Hold	50,000	–	–	﹤0.01%	3783
2021 Q2	$1.74M	Sell	50,000 -100,000	-67%	-$3.3M	﹤0.01%	3711
2021 Q1	$4.42M	Buy	150,000 +100,000	+200%	+$3.08M	﹤0.01%	2749
2020 Q4	$1.53M	Buy	+50,000	New	+$1.53M	﹤0.01%	3641

Other funds holding ELAN

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

UBS Group's ELAN Position: Q1 2026 in Review

UBS Group reduced its Elanco Animal Health (ELAN) stake by 1.2% in Q1 2026, selling an estimated $2.46M and leaving 8,572,057 shares worth $205M. The position accounts for 0.03% of the portfolio, ranked #606.

UBS Group first reported a position in ELAN in Q3 2018 and has held it in 31 quarters since. The position peaked at $353M in Q3 2020. 515 funds tracked by Wall St. Rank hold ELAN as of Q1 2026.

UBS Group held 8,572,057 shares of Elanco Animal Health worth $205M as of Q1 2026.
UBS Group sold 100,787 Elanco Animal Health shares in Q1 2026, an estimated $2.46M.
Elanco Animal Health made up 0.03% of UBS Group's portfolio in Q1 2026, its #606 holding.
UBS Group first reported a position in Elanco Animal Health in Q3 2018 and has held it in 31 quarters since.
UBS Group's Elanco Animal Health position peaked at $353M in Q3 2020.
515 funds tracked by Wall St. Rank held Elanco Animal Health as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.